Evidence map›Paper›PMID 33318181›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Biotin rescues mitochondrial dysfunction and neurotoxicity in a tauopathy model.

Kelly M Lohr, Bess Frost, Clemens Scherzer, Mel B Feany

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Natural Molecules for Brain Health and Resilience.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Modeling Path Importance for Effective Alzheimer's Disease Drug Repurposing.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2024
    Article
  18. Review
  19. Review
  20. Insights fromFrontiers in neuroscience · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Kelly M LohrDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Bess FrostDepartment of Cell Systems and Anatomy, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229.
Clemens ScherzerNeurogenomics Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Mel B FeanyDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115; mel_feany@hms.harvard.edu.
Harvard University · USBrigham and Women's Hospital · USThe University of Texas Health Science Center at San Antonio · US

Funding

Resource Component: Acquisition, maintenance and distribution of Drosophila stocksP40OD018537 · OD · TRUSTEES OF INDIANA UNIVERSITY · PI Annette L. Parks · 2014 to 2026
$13.5M
Drosophila Transgenic RNAi Resource ProjectR01GM084947 · NIGMS · HARVARD MEDICAL SCHOOL · PI PERRIMON, NORBERT · 2008 to 2019
$9.8M
Super-Resolution ImagingP30NS072030 · NINDS · HARVARD MEDICAL SCHOOL · PI REGEHR, WADE G · 2011 to 2020
$5.8M
Integrative Multi-Omic Discovery of Proximal Mechanisms Driving Age-Dependent NeurodegenerationRF1AG057331 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI FEANY, MEL B, FRAENKEL, ERNEST · 2017 to 2017
$4.8M
Genome-wide analysis of tau neurotoxicityR01AG044113 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI FEANY, MEL B · 2012 to 2016
$2.0M
ApoE: Cellular and Molecular Mechanisms Controlling Neuronal ViabilityF32NS100308 · NINDS · BRIGHAM AND WOMEN'S HOSPITAL · PI LOHR, KELLY M · 2017 to 2018
$86k
NIA NIH HHS R01 AG044113NIA NIH HHS RF1 AG057331NIGMS NIH HHS R01 GM084947NIH HHS P40 OD018537NINDS NIH HHS F32 NS100308NINDS NIH HHS P30 NS072030
6 · The paper itself

Abstract

Mitochondrial and metabolic dysfunction are often implicated in neurological disease, but effective mechanism-based therapies remain elusive. We performed a genome-scale forward genetic screen in a

Indexed as

Alzheimer DiseaseAnimalsAnimals, Genetically ModifiedBiotinBiotinylationBrainDisease Models, AnimalDrosophila melanogasterFemaleGene Expression RegulationGenetic TestingHumansMaleMiceMitochondriaNerve DegenerationBiotinNeurotoxinsbiotinDrosophilamitochondriascreentau

Identifiers

PMID33318181
PMCPMC7777082
OpenAlexW3111805946

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.